Consolidated Statements of Stockholders' Deficit - USD ($) shares in Thousands, $ in Thousands	LLC Interests [Member] Cumulative Effect, Period of Adoption, Adjusted Balance [Member]	LLC Interests [Member]	Common Stock [Member] Class A Common Stock [Member] At The Market Offering	Common Stock [Member] Class A Common Stock [Member]	Common Stock [Member] Class B Common Stock [Member]	Additional Paid-in Capital [Member] Cumulative Effect, Period of Adoption, Adjusted Balance [Member]	Additional Paid-in Capital [Member] At The Market Offering	Additional Paid-in Capital [Member]	Accumulated Deficit [Member] Cumulative Effect, Period of Adoption, Adjusted Balance [Member]	Accumulated Deficit [Member]	Cumulative Effect, Period of Adoption, Adjusted Balance [Member]	At The Market Offering	Total
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Retroactive application of recapitalization (in shares)		195,800
Beginning balance at Dec. 31, 2020	$ 136,348	$ 136,348				$ 929		$ 929	$ (47,790)	$ (47,790)	$ 89,487		$ 89,487
Beginning balance (in shares) at Dec. 31, 2020	195,800
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equitization of note payable, related party		59,590											59,590
CRIS Business Combination, net of expenses		$ (195,938)		$ 7	$ 20			233,936					38,025
CRIS Business Combination, net of expenses (in shares)		(195,800)		67,299	195,800
Share-based compensation								9,902					9,902
Vesting of earnout shares				$ 0				10,853					10,853
Vesting of earnout shares (in shares)				719
Warrants exercised				$ 0				30					30
Warrants exercised (In shares)				3
Release of warrant liability								17					17
Redeemable noncontrolling interest adjustment to fair value								(255,667)		(1,269,630)			(1,525,297)
Net loss										(40,938)			(40,938)
Ending balance at Dec. 31, 2021				$ 7	$ 20					(1,358,358)			(1,358,331)
Ending balance (in shares) at Dec. 31, 2021				68,021	195,800
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation								23,170					23,170
Issuance of common stock under the ATM, net of issuance			$ 0				$ 10,419					$ 10,419
Issuance of common stock under the ATM, net of issuance costs (in shares)			1,588
Warrants exercised and release of warrant liability				$ 0				3					3
Issuance of stock under share-based compensation plans				$ 0				0					0
Issuance of stock under share-based compensation plans (in shares)				639
Shares withheld for taxes								(25)					(25)
Redeemable noncontrolling interest adjustment to fair value								(16,034)		1,010,273			994,239
Net loss										(27,575)			(27,575)
Ending balance at Dec. 31, 2022				$ 7	$ 20			$ 17,533		$ (375,660)			$ (358,100)
Ending balance (in shares) at Dec. 31, 2022				70,248	195,800